When was Sensome founded?

Sensome was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Sensome located?

Sensome is headquartered in Paris, France.

Who is the current CEO of Sensome?

Franz Bozsak of Sensome. They have also founded 1 company.

How many employees does Sensome have?

As of Aug 31, 2026, the latest employee count at Sensome is 40.

Is Sensome a funded company?

Sensome is a funded company, having raised a total of $19.8M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 12, 2017.

When was the latest funding round of Sensome?

Sensome's latest funding was a $***** Series B round on Jan 13, 2020, with participation from 5 investors.

Where does Sensome rank among its competitors?

Sensome ranks 10th amongst 163 active competitors, of which 68 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Sonavex, which secured $3.1M in Jul, 2026.

Who are the top competitors of Sensome?

Sensome's top competitors include Augmedics, Brainlab and ClearPoint Neuro. Among them, Sonavex secured the most recent funding round in July, 2026.

Sensome - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a smart guidewire with sensors is designed to provide precise information on the clot composition. The device consists of remote monitoring technology that is capable of turning invasive vascular medical devices into connected healthcare devices.The patent-pending sensor provides non-invasive identification of the tissue composition in contact with a medical device, The device has potential applications in neurovascular, peripheral vascular and cardiovascular fields.

Website: www.sensome.com/
Social
Email ID: *****@sensome.com
Phone Number: +33 **********

Key Metrics

Founded Year

2014

Location

Paris, France

Stage

Series B

Total Funding

$19.8M in 3 rounds

Latest Funding Round

Series B, Jan 13, 2020, $*****

Investors

Kurma Partners & 7 more

Ranked

10^th among 163 active competitors

Employee Count

40 as on Aug 31, 2026

Similar Companies

Augmedics & 184 more

View Sensome's full profile

Sensome has raised a total funding of $19.8M over 3 rounds. Its first funding round was on Jul 12, 2017. Its latest funding round was a Series B round on Jan 13, 2020 for $*****. 5 investors participated in its latest round. Sensome has 8 institutional investors.

Here is the list of recent funding rounds of Sensome:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 13, 2020	8449025	Series B	4675846	2928428	5055182	4220145
Jun 11, 2018	5816041	Series A	5250592	4428647	7513542	BNP Paribas Developpement & 2 more
Jul 12, 2017	4476405	Seed	3366942	8308043	8271959	Kurma Partners & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Sensome's funding rounds and investors

The founders of Sensome is Franz Bozsak. Franz Bozsak is the CEO of Sensome.

Here are the details of Sensome's key team members:

Franz Bozsak: Founder & CEO of Sensome.
Contact Info: 1 email address

View details of Sensome's Founder profiles and Board Members

Sensome's employee count trend

Sensome has 40 employees as of Aug 26. Here is Sensome's employee count trend over the years:

Uncover Sensome's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sensome include Augmedics, Brainlab and ClearPoint Neuro. Here is the list of Top 10 competitors of Sensome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Augmedics 2014, Arlington Heights (United States), Series D	Developer of augmented reality navigation systems for spine surgical procedures	$143M	Terra Venture Partners, H.I.G. Capital & 14 others	70/100
2nd	Brainlab 1989, Munich (Germany), Series A	Manufacturer of digital hardware and software for surgical medical procedures	$7.3M	Intel Capital, EMH Partners & 2 others	65/100
3rd	ClearPoint Neuro 1998, Irvine (United States), Public	Developer of MRI-guided stereotactic system for neurological interventions	$33.7M	Oberland Capital, Collage Venture Partners ... & 5 others	64/100
4th	HRS Navigation 2015, Bengaluru (India), Seed	Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries	$7.58M	Gujarat Venture Finance, Inflection Point Ventures ... & 11 others	61/100
5th	Dilon Diagnostics 1999, Newport News (United States), Series A	Developer of technology for molecular breast imaging	$32.1M	JGB Management, F9 Investments	56/100
6th	MRI Interventions 1998, Irvine (United States), Public	MRI-guided surgery platform	$16.5M	Petrichor, Clayton Associates & 1 others	56/100
7th	Sonavex 2013, Baltimore (United States), Series A	Provider of ultrasound based imaging for Intraoperative detection of anastomotic blood clots	$33.6M	GSVP, TEDCO & 24 others	56/100
8th	OnLume 2015, Madison (United States), Series A	Developer of smart devices for fluorescence image-guided surgery	$11.5M	Luzich Partners, WARF & 3 others	56/100
9th	Intellijoint 2010, Waterloo (Canada), Series A	Developer of 3D surgical navigation tools for hip and knee replacements	$24.7M	Accelerator Centre, Golden Triangle Angel Network ... & 7 others	56/100
10th	Sensome 2014, Paris (France), Series B	Developer of a smart guidewire with sensors is designed to provide precise information on the clot composition	$19.8M	Kurma Partners, Paris Saclay Seed Fund & 6 others	55/100